| cellular amino acid metabolic process | GO:0006520 | 116 | 0.981 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.947 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.886 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.881 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.879 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.853 | |
| amine metabolic process | GO:0009308 | 44 | 0.790 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.725 | |
| chromatin modification | GO:0016568 | 298 | 0.723 | |
| positive regulation of retinoic acid receptor signaling pathway | GO:0048386 | 3 | 0.631 | |
| histone modification | GO:0016570 | 251 | 0.629 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.507 | |
| female gamete generation | GO:0007292 | 2 | 0.481 | Mouse |
| positive regulation of chromatin modification | GO:1903310 | 30 | 0.466 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.452 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.432 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.424 | |
| methylation dependent chromatin silencing | GO:0006346 | 3 | 0.422 | |
| neuron differentiation | GO:0030182 | 138 | 0.421 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 4 | 0.409 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.402 | |
| oogenesis | GO:0048477 | 2 | 0.398 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.387 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.377 | |
| positive regulation of chromosome organization | GO:2001252 | 41 | 0.340 | |
| chromatin organization | GO:0006325 | 351 | 0.314 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.308 | |
| alpha amino acid metabolic process | GO:1901605 | 72 | 0.273 | |
| regulation of chromatin organization | GO:1902275 | 56 | 0.270 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.263 | |
| response to estrogen | GO:0043627 | 47 | 0.253 | |
| cell development | GO:0048468 | 328 | 0.247 | |
| nervous system development | GO:0007399 | 293 | 0.244 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.243 | |
| response to activity | GO:0014823 | 0 | 0.231 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.229 | |
| cellular modified amino acid metabolic process | GO:0006575 | 64 | 0.216 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.214 | |
| response to hormone | GO:0009725 | 175 | 0.206 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.206 | |
| negative regulation of chromatin modification | GO:1903309 | 21 | 0.203 | |
| organ formation | GO:0048645 | 3 | 0.197 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.197 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.188 | |
| response to steroid hormone | GO:0048545 | 80 | 0.180 | |
| central nervous system development | GO:0007417 | 123 | 0.176 | |
| response to estradiol | GO:0032355 | 23 | 0.175 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.173 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.168 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.165 | |
| regulation of locomotion | GO:0040012 | 329 | 0.157 | |
| response to alcohol | GO:0097305 | 64 | 0.156 | |
| maintenance of location | GO:0051235 | 112 | 0.150 | Mouse |
| rhythmic process | GO:0048511 | 31 | 0.149 | |
| regulation of chromatin modification | GO:1903308 | 51 | 0.148 | |
| cardiovascular system development | GO:0072358 | 262 | 0.147 | |
| growth | GO:0040007 | 202 | 0.143 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.140 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.140 | |
| regulation of neuron differentiation | GO:0045664 | 70 | 0.138 | |
| organ morphogenesis | GO:0009887 | 147 | 0.138 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.131 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.131 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.128 | |
| cellular response to alcohol | GO:0097306 | 29 | 0.125 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.123 | |
| response to lipid | GO:0033993 | 206 | 0.119 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.116 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 3 | 0.115 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.114 | |
| regulation of cardiac muscle hypertrophy in response to stress | GO:1903242 | 2 | 0.113 | |
| metal ion transport | GO:0030001 | 272 | 0.110 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.106 | |
| response to metal ion | GO:0010038 | 84 | 0.104 | |
| response to inorganic substance | GO:0010035 | 127 | 0.103 | |
| regulation of transcription by chromatin organization | GO:0034401 | 1 | 0.103 | |
| brain development | GO:0007420 | 97 | 0.102 | |
| regeneration | GO:0031099 | 4 | 0.101 | |
| regulation of growth | GO:0040008 | 165 | 0.101 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.099 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.098 | |
| epithelium development | GO:0060429 | 227 | 0.096 | |
| dna conformation change | GO:0071103 | 113 | 0.096 | |
| neurological system process | GO:0050877 | 163 | 0.096 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.096 | |
| hindbrain development | GO:0030902 | 3 | 0.095 | |
| lipid metabolic process | GO:0006629 | 381 | 0.095 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.095 | |
| histone h3 k9 modification | GO:0061647 | 11 | 0.095 | |
| gland development | GO:0048732 | 48 | 0.095 | |
| chemical homeostasis | GO:0048878 | 306 | 0.094 | |
| response to corticosteroid | GO:0031960 | 15 | 0.092 | |
| response to growth factor | GO:0070848 | 205 | 0.092 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.092 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.091 | |
| muscle cell differentiation | GO:0042692 | 63 | 0.087 | |
| prostate gland development | GO:0030850 | 3 | 0.087 | |
| positive regulation of organic acid transport | GO:0032892 | 3 | 0.086 | |
| macromolecule methylation | GO:0043414 | 97 | 0.085 | |
| regulation of epithelial cell differentiation | GO:0030856 | 24 | 0.085 | |
| head development | GO:0060322 | 108 | 0.085 | |
| muscle system process | GO:0003012 | 81 | 0.084 | |
| limbic system development | GO:0021761 | 3 | 0.083 | |
| positive regulation of histone modification | GO:0031058 | 29 | 0.081 | |
| metencephalon development | GO:0022037 | 2 | 0.080 | |
| cation homeostasis | GO:0055080 | 189 | 0.080 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.076 | |
| regulation of developmental pigmentation | GO:0048070 | 2 | 0.076 | |
| nerve development | GO:0021675 | 4 | 0.075 | |
| response to extracellular stimulus | GO:0009991 | 85 | 0.074 | |
| negative regulation of histone modification | GO:0031057 | 19 | 0.073 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.071 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.070 | |
| regulation of intracellular steroid hormone receptor signaling pathway | GO:0033143 | 32 | 0.070 | |
| response to nutrient | GO:0007584 | 20 | 0.069 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.069 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.067 | |
| regulation of histone modification | GO:0031056 | 47 | 0.067 | |
| response to genistein | GO:0033595 | 1 | 0.067 | |
| membrane organization | GO:0061024 | 292 | 0.066 | |
| positive regulation of camp dependent protein kinase activity | GO:2000481 | 4 | 0.066 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.065 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.064 | |
| chromatin assembly | GO:0031497 | 61 | 0.063 | |
| response to ketone | GO:1901654 | 19 | 0.063 | |
| positive regulation of transport | GO:0051050 | 336 | 0.063 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.062 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.062 | |
| neural tube formation | GO:0001841 | 3 | 0.061 | |
| long term memory | GO:0007616 | 2 | 0.060 | |
| response to purine containing compound | GO:0014074 | 40 | 0.060 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.060 | |
| reactive nitrogen species metabolic process | GO:2001057 | 3 | 0.060 | |
| response to mercury ion | GO:0046689 | 4 | 0.059 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.059 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.059 | |
| response to radiation | GO:0009314 | 151 | 0.059 | |
| heart development | GO:0007507 | 95 | 0.058 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.057 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.057 | |
| cellular response to corticosteroid stimulus | GO:0071384 | 5 | 0.057 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.057 | |
| neurogenesis | GO:0022008 | 169 | 0.056 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.056 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.056 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.056 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.055 | |
| response to nutrient levels | GO:0031667 | 81 | 0.054 | |
| positive regulation of gliogenesis | GO:0014015 | 4 | 0.054 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.054 | |
| cation transport | GO:0006812 | 331 | 0.054 | |
| embryonic camera type eye development | GO:0031076 | 2 | 0.054 | |
| transmembrane transport | GO:0055085 | 399 | 0.053 | |
| response to dexamethasone | GO:0071548 | 1 | 0.053 | |
| sulfur compound metabolic process | GO:0006790 | 101 | 0.052 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.052 | |
| secretion by cell | GO:0032940 | 226 | 0.052 | |
| cell growth | GO:0016049 | 160 | 0.051 | |
| positive regulation of glucocorticoid receptor signaling pathway | GO:2000324 | 1 | 0.051 | |
| methylation | GO:0032259 | 106 | 0.050 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.050 | |
| memory | GO:0007613 | 3 | 0.050 | |
| immune system development | GO:0002520 | 195 | 0.050 | |
| response to glucocorticoid | GO:0051384 | 13 | 0.049 | |
| response to cytokine | GO:0034097 | 232 | 0.049 | |
| single organism reproductive process | GO:0044702 | 98 | 0.049 | Mouse |
| regulation of glucocorticoid receptor signaling pathway | GO:2000322 | 2 | 0.048 | |
| oocyte differentiation | GO:0009994 | 2 | 0.048 | |
| eye development | GO:0001654 | 42 | 0.048 | |
| regulation of neurogenesis | GO:0050767 | 82 | 0.048 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.047 | |
| generation of neurons | GO:0048699 | 152 | 0.047 | |
| regionalization | GO:0003002 | 29 | 0.047 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.047 | |
| circulatory system development | GO:0072359 | 262 | 0.046 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.045 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.045 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.045 | |
| potassium ion transport | GO:0006813 | 62 | 0.045 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.044 | |
| tube morphogenesis | GO:0035239 | 95 | 0.044 | |
| negative regulation of transcription initiation from rna polymerase ii promoter | GO:0060633 | 3 | 0.044 | |
| fibroblast proliferation | GO:0048144 | 33 | 0.044 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.043 | |
| ossification | GO:0001503 | 121 | 0.043 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.043 | |
| cellular response to lipid | GO:0071396 | 127 | 0.043 | |
| dna templated transcription initiation | GO:0006352 | 35 | 0.043 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.043 | |
| protein localization to organelle | GO:0033365 | 280 | 0.043 | |
| negative regulation of histone acetylation | GO:0035067 | 6 | 0.041 | |
| neuronal ion channel clustering | GO:0045161 | 2 | 0.041 | |
| negative regulation of cytosolic calcium ion concentration | GO:0051481 | 1 | 0.041 | |
| histone acetylation | GO:0016573 | 93 | 0.040 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.040 | |
| muscle adaptation | GO:0043500 | 12 | 0.039 | |
| response to cocaine | GO:0042220 | 1 | 0.039 | |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.039 | |
| outflow tract septum morphogenesis | GO:0003148 | 4 | 0.039 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.039 | |
| regulation of protein acetylation | GO:1901983 | 25 | 0.039 | |
| response to acid chemical | GO:0001101 | 66 | 0.039 | |
| arginine metabolic process | GO:0006525 | 3 | 0.037 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.036 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.036 | |
| post embryonic development | GO:0009791 | 2 | 0.036 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.036 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.036 | |
| protein alkylation | GO:0008213 | 74 | 0.036 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.035 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.035 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.035 | |
| ion homeostasis | GO:0050801 | 230 | 0.035 | |
| muscle tissue development | GO:0060537 | 62 | 0.035 | |
| cellular response to decreased oxygen levels | GO:0036294 | 51 | 0.035 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.034 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.034 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.034 | |
| chromatin silencing | GO:0006342 | 12 | 0.033 | |
| microtubule based process | GO:0007017 | 210 | 0.033 | |
| positive regulation of protein complex assembly | GO:0031334 | 86 | 0.033 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.033 | |
| tube development | GO:0035295 | 125 | 0.033 | |
| protein targeting | GO:0006605 | 187 | 0.033 | |
| cell cycle g2 m phase transition | GO:0044839 | 43 | 0.033 | |
| regulation of nitric oxide mediated signal transduction | GO:0010749 | 2 | 0.033 | |
| neural tube closure | GO:0001843 | 3 | 0.032 | |
| camera type eye development | GO:0043010 | 25 | 0.032 | |
| protein acylation | GO:0043543 | 138 | 0.032 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.032 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.032 | |
| regulation of retinoic acid receptor signaling pathway | GO:0048385 | 9 | 0.032 | |
| positive regulation of ion transport | GO:0043270 | 87 | 0.031 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.031 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.031 | |
| regulation of cell growth | GO:0001558 | 135 | 0.031 | |
| positive regulation of muscle hypertrophy | GO:0014742 | 6 | 0.031 | |
| microtubule organizing center organization | GO:0031023 | 62 | 0.031 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.031 | |
| negative regulation of calcium mediated signaling | GO:0050849 | 4 | 0.030 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.030 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.030 | |
| response to camp | GO:0051591 | 25 | 0.030 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.030 | |
| transcription initiation from rna polymerase ii promoter | GO:0006367 | 27 | 0.030 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.030 | |
| dna modification | GO:0006304 | 27 | 0.030 | |
| heart morphogenesis | GO:0003007 | 48 | 0.029 | |
| purine containing compound biosynthetic process | GO:0072522 | 88 | 0.029 | |
| mapk cascade | GO:0000165 | 288 | 0.029 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.029 | |
| chromatin remodeling | GO:0006338 | 55 | 0.029 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 2 | 0.029 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 48 | 0.028 | |
| actin filament based process | GO:0030029 | 224 | 0.028 | |
| regulation of cell development | GO:0060284 | 161 | 0.028 | |
| dna repair | GO:0006281 | 198 | 0.028 | |
| dna methylation or demethylation | GO:0044728 | 19 | 0.028 | |
| cellular response to acid chemical | GO:0071229 | 44 | 0.027 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.027 | |
| regulation of cell migration | GO:0030334 | 289 | 0.027 | |
| regulation of synaptic plasticity | GO:0048167 | 3 | 0.027 | |
| hemopoiesis | GO:0030097 | 180 | 0.027 | |
| sensory perception | GO:0007600 | 103 | 0.027 | |
| forebrain regionalization | GO:0021871 | 3 | 0.027 | |
| maintenance of location in cell | GO:0051651 | 62 | 0.027 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.027 | |
| stem cell differentiation | GO:0048863 | 93 | 0.027 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.027 | |
| embryonic placenta development | GO:0001892 | 1 | 0.026 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 0.026 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 1 | 0.026 | |
| multi organism cellular process | GO:0044764 | 156 | 0.026 | |
| neuron development | GO:0048666 | 113 | 0.026 | |
| sensory organ development | GO:0007423 | 52 | 0.026 | |
| positive regulation of ubiquitin protein transferase activity | GO:0051443 | 18 | 0.026 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.026 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.026 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 99 | 0.026 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 79 | 0.025 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.025 | |
| cellular potassium ion transport | GO:0071804 | 60 | 0.025 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.025 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.025 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.025 | |
| positive regulation of cell size | GO:0045793 | 3 | 0.025 | |
| viral process | GO:0016032 | 146 | 0.025 | |
| positive regulation of ligase activity | GO:0051351 | 19 | 0.025 | |
| tube closure | GO:0060606 | 3 | 0.025 | |
| macromolecule deacylation | GO:0098732 | 41 | 0.025 | |
| muscle structure development | GO:0061061 | 98 | 0.025 | |
| lymphocyte activation | GO:0046649 | 133 | 0.025 | |
| striated muscle cell differentiation | GO:0051146 | 43 | 0.024 | |
| reproductive process | GO:0022414 | 106 | 0.024 | Mouse |
| myosin filament assembly | GO:0031034 | 2 | 0.024 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 29 | 0.024 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.024 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.024 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.024 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.024 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.024 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.024 | |
| regulation of ligase activity | GO:0051340 | 29 | 0.024 | |
| regulation of cardiac muscle adaptation | GO:0010612 | 2 | 0.023 | |
| histone arginine methylation | GO:0034969 | 6 | 0.023 | |
| response to toxic substance | GO:0009636 | 37 | 0.023 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.023 | |
| protein deacylation | GO:0035601 | 39 | 0.023 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.023 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.023 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 37 | 0.023 | |
| tissue regeneration | GO:0042246 | 3 | 0.023 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.022 | |
| oocyte development | GO:0048599 | 1 | 0.022 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.022 | |
| regulation of body fluid levels | GO:0050878 | 99 | 0.022 | |
| sensory perception of sound | GO:0007605 | 37 | 0.022 | |
| melanocyte differentiation | GO:0030318 | 2 | 0.022 | |
| response to drug | GO:0042493 | 81 | 0.022 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.022 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.022 | |
| hepaticobiliary system development | GO:0061008 | 10 | 0.021 | |
| positive regulation of organ growth | GO:0046622 | 2 | 0.021 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 20 | 0.021 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.021 | |
| response to hypoxia | GO:0001666 | 96 | 0.021 | |
| aging | GO:0007568 | 66 | 0.021 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.021 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.021 | |
| regulation of transcription by galactose | GO:0000409 | 1 | 0.021 | |
| developmental pigmentation | GO:0048066 | 12 | 0.021 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.021 | |
| inner ear morphogenesis | GO:0042472 | 4 | 0.021 | |
| coenzyme metabolic process | GO:0006732 | 65 | 0.021 | |
| retinoic acid receptor signaling pathway | GO:0048384 | 13 | 0.020 | |
| negative regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043154 | 46 | 0.020 | |
| protein catabolic process | GO:0030163 | 325 | 0.020 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.020 | |
| histone exchange | GO:0043486 | 3 | 0.020 | |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 28 | 0.020 | |
| system process | GO:0003008 | 349 | 0.020 | |
| negative regulation of calcineurin nfat signaling cascade | GO:0070885 | 2 | 0.020 | |
| leukocyte activation | GO:0045321 | 164 | 0.020 | |
| cell activation | GO:0001775 | 213 | 0.020 | |
| negative regulation of histone methylation | GO:0031061 | 6 | 0.020 | |
| photoreceptor cell differentiation | GO:0046530 | 2 | 0.020 | |
| forelimb morphogenesis | GO:0035136 | 4 | 0.020 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.020 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.020 | |
| carboxylic acid transport | GO:0046942 | 63 | 0.019 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.019 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.019 | |
| cognition | GO:0050890 | 43 | 0.019 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.019 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.019 | |
| regulation of anion transport | GO:0044070 | 25 | 0.019 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.019 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.019 | |
| cell morphogenesis | GO:0000902 | 296 | 0.019 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 108 | 0.019 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.019 | |
| cellular response to epinephrine stimulus | GO:0071872 | 2 | 0.019 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.019 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.019 | |
| megakaryocyte differentiation | GO:0030219 | 25 | 0.019 | |
| cell projection organization | GO:0030030 | 252 | 0.019 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.018 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 85 | 0.018 | |
| regulation of cell cycle arrest | GO:0071156 | 36 | 0.018 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.018 | |
| regulation of oxidoreductase activity | GO:0051341 | 43 | 0.018 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.018 | |
| locomotory behavior | GO:0007626 | 1 | 0.018 | |
| t cell activation | GO:0042110 | 99 | 0.018 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.018 | |
| regulation of cardiac muscle hypertrophy | GO:0010611 | 10 | 0.018 | |
| negative regulation of histone h3 k9 methylation | GO:0051573 | 3 | 0.018 | |
| small molecule catabolic process | GO:0044282 | 92 | 0.018 | |
| primary neural tube formation | GO:0014020 | 3 | 0.018 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.018 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.018 | |
| purine nucleotide biosynthetic process | GO:0006164 | 84 | 0.017 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.017 | |
| cellular response to oxygen levels | GO:0071453 | 55 | 0.017 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 41 | 0.017 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 24 | 0.017 | |
| calcium ion transmembrane transport | GO:0070588 | 76 | 0.017 | |
| regulation of growth rate | GO:0040009 | 1 | 0.017 | |
| negative regulation of reactive oxygen species metabolic process | GO:2000378 | 11 | 0.017 | |
| regulation of muscle system process | GO:0090257 | 53 | 0.017 | |
| forebrain development | GO:0030900 | 26 | 0.017 | |
| protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:0042787 | 37 | 0.017 | |
| response to water | GO:0009415 | 2 | 0.017 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.017 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.016 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.016 | |
| reproductive system development | GO:0061458 | 56 | 0.016 | Mouse |
| response to oxygen levels | GO:0070482 | 100 | 0.016 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.016 | |
| positive regulation of dendritic spine development | GO:0060999 | 2 | 0.016 | |
| response to bacterium | GO:0009617 | 144 | 0.016 | |
| urogenital system development | GO:0001655 | 65 | 0.016 | |
| hormone metabolic process | GO:0042445 | 61 | 0.016 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.016 | |
| negative regulation of peptidyl lysine acetylation | GO:2000757 | 8 | 0.016 | |
| pattern specification process | GO:0007389 | 43 | 0.016 | |
| axis elongation | GO:0003401 | 4 | 0.016 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.016 | |
| regulation of ion homeostasis | GO:2000021 | 73 | 0.016 | |
| response to vitamin | GO:0033273 | 13 | 0.016 | |
| multicellular organismal response to stress | GO:0033555 | 1 | 0.016 | |
| embryonic eye morphogenesis | GO:0048048 | 2 | 0.016 | |
| regulation of ion transport | GO:0043269 | 189 | 0.016 | |
| organ growth | GO:0035265 | 12 | 0.016 | |
| rhythmic behavior | GO:0007622 | 2 | 0.016 | |
| histone deacetylation | GO:0016575 | 32 | 0.016 | |
| regulation of dna methylation | GO:0044030 | 2 | 0.016 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.015 | |
| divalent inorganic cation transport | GO:0072511 | 158 | 0.015 | |
| carbon catabolite activation of transcription | GO:0045991 | 3 | 0.015 | |
| somitogenesis | GO:0001756 | 2 | 0.015 | |
| cellular response to nutrient | GO:0031670 | 12 | 0.015 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.015 | |
| male meiosis | GO:0007140 | 1 | 0.015 | |
| regulation of transmembrane transporter activity | GO:0022898 | 74 | 0.015 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.015 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.015 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.015 | |
| cellular hormone metabolic process | GO:0034754 | 41 | 0.015 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.015 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 48 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.015 | |
| immune response | GO:0006955 | 307 | 0.015 | |
| dna hypermethylation | GO:0044026 | 1 | 0.015 | |
| cardiac muscle hypertrophy | GO:0003300 | 14 | 0.015 | |
| dna methylation on cytosine | GO:0032776 | 3 | 0.015 | |
| regulation of viral process | GO:0050792 | 103 | 0.015 | |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.014 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.014 | |
| regulation of translation | GO:0006417 | 89 | 0.014 | |
| regulation of myelination | GO:0031641 | 1 | 0.014 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.014 | |
| developmental growth | GO:0048589 | 48 | 0.014 | |
| regulation of cell activation | GO:0050865 | 125 | 0.014 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.014 | |
| single organism membrane organization | GO:0044802 | 268 | 0.014 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.014 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.014 | |
| positive regulation of cardiac muscle cell differentiation | GO:2000727 | 4 | 0.014 | |
| organelle assembly | GO:0070925 | 176 | 0.014 | |
| regulation of binding | GO:0051098 | 111 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.014 | |
| fat cell differentiation | GO:0045444 | 32 | 0.014 | |
| angiogenesis | GO:0001525 | 147 | 0.014 | |
| hormone mediated signaling pathway | GO:0009755 | 22 | 0.014 | |
| regulation of cell motility | GO:2000145 | 299 | 0.014 | |
| positive regulation of transcription by galactose | GO:0000411 | 1 | 0.014 | |
| regulation of jak stat cascade | GO:0046425 | 44 | 0.014 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.014 | |
| gene silencing | GO:0016458 | 49 | 0.014 | |
| negative regulation of endopeptidase activity | GO:0010951 | 84 | 0.014 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.014 | |
| positive regulation of potassium ion transport | GO:0043268 | 15 | 0.014 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.013 | |
| potassium ion transmembrane transport | GO:0071805 | 60 | 0.013 | |
| regulation of muscle adaptation | GO:0043502 | 10 | 0.013 | |
| protein ubiquitination | GO:0016567 | 314 | 0.013 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.013 | |
| histone methylation | GO:0016571 | 60 | 0.013 | |
| organic acid biosynthetic process | GO:0016053 | 97 | 0.013 | |
| negative regulation of growth | GO:0045926 | 97 | 0.013 | |
| epithelial cell development | GO:0002064 | 34 | 0.013 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 60 | 0.013 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.013 | |
| maintenance of protein location in cell | GO:0032507 | 56 | 0.013 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.013 | |
| positive regulation of nervous system development | GO:0051962 | 54 | 0.013 | |
| embryonic hemopoiesis | GO:0035162 | 4 | 0.013 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 187 | 0.013 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.013 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 109 | 0.013 | |
| positive regulation of jak stat cascade | GO:0046427 | 35 | 0.013 | |
| cerebellum development | GO:0021549 | 2 | 0.013 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.013 | |
| response to testosterone | GO:0033574 | 1 | 0.013 | |
